The BMJ reported the generic approval was made possible after Novo Nordisk did not pay a C$250 annual fee [Source: bmj.com/content/393/bmj-2026-597166]
Similar results of heart benefit were previously seen for the injectable version of semaglutide in people with type 2 diabetes
Remember, your healthcare provider is your best resource for personalized advice and guidance
Similarly, symptoms of gallbladder diseasesuch as pain in the right upper abdomen, fever, or yellowing of the skin or eyesrequire prompt medical review, as GLP-1 receptor agonists have been associated with an increased risk of gallstones
Remove both the outer and inner needle caps
GLP-1 (glucagon-like peptide-1) receptor agonists are medications designed to regulate blood sugar, reduce appetite, and slow digestion